Recombinant Human PD-L2/CD273 protein (His Tag)
Species
Human
Purity
>90 %, SDS-PAGE
Tag
His Tag
Activity
not tested
Cat no : Eg0507
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human PD-L2 protein Leu20-Pro219 (Accession# Q9BQ51-1) with a His tag at the C-terminus. |
GeneID | 80380 |
Accession | Q9BQ51-1 |
PredictedSize | 26.4 kDa |
SDS-PAGE | 34-50 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Programmed cell death ligand 2 (PD-L2, also known as CD273, or B7-DC), is one of the B7 family molecules which are type I transmembrane proteins belonging to the immunoglobulin superfamily. PD-L2 was identified both by its homology to PD-L1 and by analysis of genes differentially expressed in libraries generated from dendritic cells (DC) and activated macrophages. It consists of an extracellular region containing an IgV-like domain and an IgC-like domain, a transmembrane region, and a short cytoplasmic domain. PD-L2 is a second ligand for PD-1, a costimulatory molecule that plays an inhibitory role in regulating T-cell activation.
References:
1.S Y Tseng, et al. (2001) J Exp Med. 193(7):839-46. 2.Y Latchman, et al. (2001) Nat Immunol. 2(3):261-8. 3.Spencer C Liang, et al. (2003) Eur J Immunol. 33(10):2706-16.